The efficacy of niacin supplementation in type 2 diabetes patients: Study protocol of a randomized controlled trial

BACKGROUND: Dyslipidemia is a main risk factor of cardiovascular disease in the diabetic patients. Niacin was found acutely to decrease the plasma concentration of free fatty acids by inhibiting their mobilization from adipose tissue. This present study is a double blinded, randomized, and prospecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Xiaoying, Wang, Shunyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
4300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9282106/
https://www.ncbi.nlm.nih.gov/pubmed/33761625
http://dx.doi.org/10.1097/MD.0000000000022272

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9282106/
https://www.ncbi.nlm.nih.gov/pubmed/33761625
http://dx.doi.org/10.1097/MD.0000000000022272

Ejemplares similares